Therefore, we hypothesize that timely treatment with levodopa and a partial agonist at dopamine D1 receptors in patients with clinically diagnosed early PD can not only improve those patients' motor symptoms but can also help prevent the occurrence of OAB symptoms and the progression of LUT dysfunction. The gene discussed is DRD1; the disease is Parkinson disease.